{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=indacaterol&page=2", "query": { "intervention": "indacaterol", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=indacaterol&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-25T21:25:18.310Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01727141", "title": "A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "QAB149", "type": "DRUG" }, { "name": "NVA237", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1042, "start_date": "2012-11", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-03-29", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Mesa, Arizona + 60 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01727141" }, { "nct_id": "NCT01089127", "title": "Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Salmeterol 50 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 552, "start_date": "2010-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 69, "location_summary": "Florence, Alabama • Jasper, Alabama • Phoenix, Arizona + 63 more", "locations": [ { "city": "Florence", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Searcy", "state": "Arkansas" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01089127" }, { "nct_id": "NCT02487446", "title": "Efficacy and Safety Study of QVA149 in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "QVA149", "type": "DRUG" }, { "name": "Umeclidinium/vilanterol", "type": "DRUG" }, { "name": "Placebo (umeclidinium/vilanterol)", "type": "DRUG" }, { "name": "Placebo (QVA149)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 357, "start_date": "2015-07-28", "completion_date": "2016-09-12", "has_results": true, "last_update_posted_date": "2017-12-26", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 58, "location_summary": "Andalusia, Alabama • Anniston, Alabama • Jasper, Alabama + 52 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Alabama" }, { "city": "Multiple Locations", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02487446" }, { "nct_id": "NCT01156844", "title": "Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Persistent Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 191, "start_date": "2010-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-17", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 21, "location_summary": "Anniston, Alabama • Cypress, California • Fresno, California + 16 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Cypress", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01156844" }, { "nct_id": "NCT02867761", "title": "RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD (Chronic Obstructive Pulmonary Disease)" ], "interventions": [ { "name": "Indacaterol/Glycopyrrolate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 780, "start_date": "2017-08-29", "completion_date": "2021-07-07", "has_results": true, "last_update_posted_date": "2023-04-13", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02867761" }, { "nct_id": "NCT01079130", "title": "Efficacy and Safety of Different Doses of Indacaterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo to Indacaterol", "type": "DRUG" }, { "name": "Placebo to Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 511, "start_date": "2010-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 71, "location_summary": "Glendale, Arizona • Scottsdale, Arizona • Encinitas, California + 64 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01079130" }, { "nct_id": "NCT00624286", "title": "Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol 150 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 416, "start_date": "2008-02", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2011-08-18", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 118, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Jasper, Alabama + 105 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624286" }, { "nct_id": "NCT00877383", "title": "Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "Indacaterol 150 μg", "type": "DRUG" }, { "name": "Tiotropium 18 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1142, "start_date": "2009-04", "completion_date": "2010-02", "has_results": true, "last_update_posted_date": "2011-08-25", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 116, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Jasper, Alabama + 102 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00877383" }, { "nct_id": "NCT02554786", "title": "A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Indacaterol acetate/Mometasone furoate", "type": "DRUG" }, { "name": "Mometasone furoate", "type": "DRUG" }, { "name": "Salmeterol xinafoate/fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 2216, "start_date": "2015-12-29", "completion_date": "2019-06-28", "has_results": true, "last_update_posted_date": "2020-03-05", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Los Angeles, California • Orange, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02554786" }, { "nct_id": "NCT00416702", "title": "Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatic Insufficiency" ], "interventions": [ { "name": "QAB149", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 32, "start_date": "2006-11", "completion_date": "2008-03", "has_results": false, "last_update_posted_date": "2008-06-10", "last_synced_at": "2026-09-25T21:25:18.310Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00416702" } ] }